Guest guest Posted July 25, 2008 Report Share Posted July 25, 2008 "Abiraterone could potentially treat up to 80% of patients with adeadly form of the disease resistant to currently available chemotherapy,they say. The drug works by blocking the hormones which fuel the cancer. TheInstitute of Cancer Research hopes a simple pill form will be available intwo to three years."This certainly runs counter to recent notes suggesting that hormone manipulation was without use in prostate cancer. It's getting clear as mud!JB Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.